Drug:
Reaction: DRY SKIN
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25138756 |
US |
36 | 2 |
Skin fissures, Skin weeping, Dry skin, Pruritus, Insomnia, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 2 | 25138817 |
US |
30 | 1 |
Eczema, Pruritus, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3 | 25138840 |
US |
15 | 2 |
Eczema, Pruritus, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 4 | 25138930 |
US |
4 | 1 |
Staphylococcal infection, Skin fissures, Dry skin, Pruritus, Rash, |
||||
DUPILUMAB, ALBUTEROL SULFATE, MUPIROCIN, MUPIROCIN CALCIUM, DIPHENHYDRAMINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PYRITHIONE ZINC, |
||||
| 5 | 25138962 |
US |
68 | 2 |
Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 6 | 25139012 |
US |
66 | 1 |
Inappropriate antidiuretic hormone secretion, Cerebral haemorrhage, Intervertebral disc disorder, Seizure cluster, Scar, Feeling abnormal, Disturbance in attention, Skin fissures, Abnormal behaviour, Skin burning sensation, Cellulitis, Depressed mood, Blood glucose increased, Dry skin, Weight decreased, Liver disorder, Depression, Cerebral disorder, Initial insomnia, |
||||
DUPILUMAB, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, TIRZEPATIDE, ALBUTEROL SULFATE, ALPRAZOLAM, AMLODIPINE BESYLATE, GABAPENTIN, HYDRALAZINE HYDROCHLORIDE, INSULIN GLARGINE, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ZONISAMIDE, MONTELUKAST, NEBIVOLOL HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, SEMAGLUTIDE, PANTOPRAZOLE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, METHOCARBAMOL, METHOCARBAMOL TABLETS, BUPRENORPHINE, |
||||
| 7 | 25139399 |
CA |
2 | |
Large intestinal stenosis, Large intestinal obstruction, Dry skin, |
||||
RISANKIZUMAB-RZAA, |
||||
| 8 | 25139685 |
US |
1 | |
Swelling of eyelid, Dry skin, Psoriatic arthropathy, Skin texture abnormal, Therapeutic product effect decreased, |
||||
ADALIMUMAB, |
||||
| 9 | 25140863 |
US |
1 | |
Dystonia, Gait disturbance, Speech disorder, Dysphonia, Fall, Weight increased, Vision blurred, Chest pain, Dysphagia, Constipation, Pollakiuria, Joint swelling, Myalgia, Dry skin, Depression, Dysarthria, Muscle rigidity, Posture abnormal, Scoliosis, Reduced facial expression, Bradykinesia, Loss of personal independence in daily activities, On and off phenomenon, Weight decreased, Anxiety, Insomnia, Dyskinesia, |
||||
OPICAPONE, EPINEPHRINE, ADRENALINUM, LEVODOPA, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, PRAMIPEXOLE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, POLYETHYLENE GLYCOL 3350, |
||||
| 10 | 25140935 |
PL |
57 | 2 |
Skin lesion, Rash pustular, Eyelid oedema, Pruritus, Dry skin, Nail fold inflammation, |
||||
PANITUMUMAB, PANITUMUMAB, FLUOROURACIL, FLUOROURACIL, |
||||
| 11 | 25141113 |
CO |
45 | 2 |
Abdominal distension, Abdominal pain, Papule, Burning sensation, Skin lesion, Hypersensitivity, Eye irritation, Eye pruritus, Acne, Dry eye, Ocular hyperaemia, Rash, Dry skin, |
||||
PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, |
||||
| 12 | 25141357 |
US |
24 | 2 |
Anxiety, Sinus operation, Wisdom teeth removal, Lip dry, Chapped lips, Adenoidectomy, Asthma, Acne, Anaemia, Dry skin, Tonsillectomy, Photosensitivity reaction, Corrective lens user, Psoriasis, Depression, Nasal dryness, Eye disorder, |
||||
ISOTRETINOIN, |
||||
| 13 | 25141377 |
JP |
59 | 2 |
Malignant neoplasm progression, Breast cancer female, Ascites, Pleural effusion, Platelet count decreased, Nausea, Malaise, White blood cell count decreased, Haemoglobin decreased, Dry skin, Product dose omission in error, |
||||
TALAZOPARIB, |
||||
| 14 | 25141403 |
US |
2 | 1 |
Dermatitis atopic, Dry skin, Skin exfoliation, Therapeutic response shortened, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
| 15 | 25141461 |
US |
26 | 1 |
Dry skin, Blister, Condition aggravated, |
||||
DUPILUMAB, |
||||
| 16 | 25141562 |
US |
24 | 2 |
Dermatitis atopic, Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 17 | 25141606 |
US |
26 | 2 |
Rebound eczema, Dry skin, Pruritus, Intentional dose omission, Inappropriate schedule of product administration, |
||||
DUPILUMAB, BETAMETHASONE DIPROPIONATE, |
||||
| 18 | 25141616 |
US |
29 | 1 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 19 | 25142554 |
US |
2 | |
Dermatitis atopic, Dry skin, Eyelid skin dryness, |
||||
DUPILUMAB, |
||||
| 20 | 25144834 |
29 | 1 | |
Dry skin, Eye pruritus, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, DUPILUMAB, |
||||
| 21 | 25138126 |
US |
33 | 2 |
Dry skin, Vision blurred, Condition aggravated, Rash, Dry eye, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 22 | 25138308 |
US |
48 | 2 |
Dermatitis, Seasonal allergy, Dry skin, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 23 | 25138367 |
US |
||
Rhinorrhoea, Dry skin, Photosensitivity reaction, Diarrhoea, |
||||
OSIMERTINIB, |
||||
| 24 | 25138544 |
US |
2 | 2 |
Dry skin, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 25 | 25138665 |
US |
26 | 2 |
Pruritus, Dry skin, Skin exfoliation, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 26 | 25137150 |
US |
71 | 1 |
Skin fissures, Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 27 | 25137369 |
US |
11 | 2 |
Skin fissures, Skin weeping, Dry skin, Skin exfoliation, Pruritus, Injection site pruritus, |
||||
DUPILUMAB, |
||||
| 28 | 25137513 |
US |
1 | |
Rebound eczema, Dry skin, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 29 | 25137539 |
US |
1 | |
Skin burning sensation, Erythema, Headache, Dry skin, Eye irritation, |
||||
UPADACITINIB, |
||||
| 30 | 25137930 |
US |
81 | 1 |
Skin fissures, Dry skin, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 31 | 25138089 |
US |
11 | 2 |
Dry skin, Injection site paraesthesia, Injection site hypoaesthesia, Pruritus, Dermatitis atopic, Skin weeping, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 32 | 25132184 |
US |
51 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 33 | 25132202 |
US |
2 | |
Dry skin, Skin haemorrhage, Skin exfoliation, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 34 | 25132687 |
US |
1 | |
Dysphonia, Fatigue, Ill-defined disorder, Abdominal pain upper, Tongue discomfort, Skin lesion, Dry skin, |
||||
PEMBROLIZUMAB, LENVATINIB, LENVATINIB, |
||||
| 35 | 25132939 |
GB |
71 | 1 |
Blindness, Myocardial infarction, Abdominal discomfort, Malaise, Headache, Nausea, Diarrhoea, Hallucination, Malaise, COVID-19, Dizziness, Tinnitus, Arthralgia, Pain of skin, Peripheral swelling, Disturbance in attention, Cognitive disorder, Memory impairment, Visual impairment, Diplopia, Sleep terror, Transient ischaemic attack, Fatigue, Vomiting, Pericarditis, Cardiospasm, Dyspnoea, Atrial tachycardia, Anxiety, Muscular weakness, Feeling abnormal, Insomnia, Subarachnoid haemorrhage, Heart rate increased, Muscle twitching, Abdominal pain upper, Dehydration, Hyperhidrosis, Rash papular, Lip swelling, Pruritus, Palmoplantar keratoderma, Dry skin, Angioedema, Chest pain, Palpitations, Tachycardia, Off label use, Intentional product misuse, Pain, Anosmia, Eye pruritus, Facial pain, Abdominal discomfort, Carotid artery occlusion, Back pain, Adverse drug reaction, Abdominal pain upper, Blood glucose increased, Amnesia, Immunisation, Alopecia, Pyrexia, Tension headache, Migraine, Vasculitis, Intentional product use issue, Pruritus genital, Ventricular tachycardia, |
||||
BISOPROLOL FUMARATE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, HYDROCHLOROTHIAZIDE, ISOSORBIDE DINITRATE, ISOSORBIDE MONONITRATE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LINAGLIPTIN, NAPROXEN, NAPROXEN SODIUM, SIMVASTATIN, APIXABAN, AMITRIPTYLINE HYDROCHLORIDE, LOSARTAN POTASSIUM, LOSARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DAPAGLIFLOZIN, DIGOXIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SIMVASTATIN, LANSOPRAZOLE, BISOPROLOL FUMARATE, |
||||
| 36 | 25133393 |
US |
5 | 1 |
Dermatitis atopic, Dry skin, Skin fissures, |
||||
DUPILUMAB, |
||||
| 37 | 25133527 |
ES |
||
Thrombocytopenia, Neutropenia, Leukopenia, Neuropathy peripheral, Unevaluable event, Insomnia, Off label use, Stress, Anxiety, Cough, Dyspnoea, Weight decreased, Anaemia, Chest pain, Fatigue, Nausea, Decreased appetite, Constipation, Vomiting, Ageusia, Alopecia, Mucosal inflammation, Oral pain, Depression, Dry skin, Dry mouth, Diarrhoea, Pyrexia, Influenza like illness, Myalgia, Rash, Arthralgia, Dyspnoea, Fluid retention, Abdominal pain, Headache, Mood altered, Infection, |
||||
DENOSUMAB, BEVACIZUMAB, |
||||
| 38 | 25133957 |
US |
19 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 39 | 25133985 |
US |
2 | |
Dry skin, Rash, |
||||
TRAMETINIB, TRAMETINIB, |
||||
| 40 | 25134002 |
US |
55 | 2 |
Cheilitis, Drug hypersensitivity, Lip dry, Dry skin, Pruritus, Dry eye, Eye irritation, Dermatitis atopic, Condition aggravated, Rash, |
||||
DUPILUMAB, |
||||
| 41 | 25134054 |
US |
32 | 1 |
Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 42 | 25134100 |
US |
44 | 1 |
Dry skin, Paraesthesia, Pruritus, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 43 | 25134876 |
DE |
68 | 1 |
Dysstasia, Ill-defined disorder, Sensory disturbance, Dizziness, Alopecia, Dry skin, Pruritus, |
||||
CARBOPLATIN, ATEZOLIZUMAB, ETOPOSIDE, |
||||
| 44 | 25135101 |
US |
1 | 2 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 45 | 25135107 |
US |
32 | 2 |
Dehydration, Cardiac disorder, Abdominal pain upper, Oropharyngeal pain, Dizziness, Eye disorder, Erythema, Dry skin, Bradyphrenia, Oscillopsia, Hepatic enzyme increased, White blood cell count decreased, Neutrophil count decreased, Papule, Fatigue, Cough, Rash, Nausea, Diarrhoea, Product dose omission issue, |
||||
NIROGACESTAT, |
||||
| 46 | 25135588 |
US |
2 | |
Adrenal gland operation, Lethargy, Chapped lips, Drug effect less than expected, Lip exfoliation, Nightmare, Muscle spasms, Skin exfoliation, Lip dry, Constipation, Cortisol increased, Dehydration, Dyspepsia, Urinary tract infection, Headache, Nausea, Fatigue, Dry skin, Abdominal pain upper, Dizziness, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, SEMAGLUTIDE, INCLISIRAN, |
||||
| 47 | 25135645 |
US |
62 | 1 |
Rash, Dry skin, |
||||
LAZERTINIB, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, GABAPENTIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NAPROXEN, NAPROXEN SODIUM, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OXYCODONE, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES 8.6 MG TABLETS, SIMVASTATIN, DENOSUMAB, |
||||
| 48 | 25135795 |
US |
79 | 2 |
Acne, Skin disorder, Haemorrhage, Skin exfoliation, Dry skin, Drug ineffective, |
||||
CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 49 | 25135822 |
US |
8 | 1 |
Sleep disorder, Dry skin, Memory impairment, Eczema, Therapeutic response decreased, Eosinophilic oesophagitis, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, GABAPENTIN, |
||||
| 50 | 25136149 |
US |
2 | |
Skin erosion, Dry skin, Skin atrophy, Skin haemorrhage, |
||||
DUPILUMAB, BECLOMETHASONE DIPROPIONATE HFA, ALBUTEROL SULFATE, MONTELUKAST SODIUM, MONTELUKAST, |
||||
| 51 | 25136275 |
US |
2 | |
Dry skin, Rash macular, |
||||
DUPILUMAB, |
||||
| 52 | 25136289 |
US |
69 | 2 |
Dry skin, |
||||
LENALIDOMIDE, |
||||
| 53 | 25126356 |
US |
1 | |
Skin exfoliation, Pruritus, Dry skin, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ORAL SEMAGLUTIDE, DAPAGLIFLOZIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, GLIMEPIRIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 54 | 25126837 |
CA |
73 | 2 |
Arthralgia, Blood pressure increased, Chest discomfort, Chest pain, Condition aggravated, Diarrhoea, Dry skin, Headache, Mitral valve incompetence, Pain, Pain in extremity, Peripheral swelling, Poor quality sleep, White blood cell disorder, |
||||
RIBOCICLIB, RIBOCICLIB, MAVACAMTEN, MAVACAMTEN, ATENOLOL, CANDESARTAN, FULVESTRANT, MAGNESIUM, MELATONIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SELENIUM, VITAMIN C, ERGOCALCIFEROL, ZOLEDRONIC ACID, |
||||
| 55 | 25127208 |
US |
1 | |
Dry skin, Pollakiuria, Fatigue, Therapeutic product effect incomplete, |
||||
BIMEKIZUMAB, |
||||
| 56 | 25127826 |
CA |
42 | 2 |
Blister, Brain fog, Cerebral disorder, Depression, Dry skin, Eczema, Fatigue, Gastrointestinal disorder, Necrotising fasciitis streptococcal, Psoriasis, Pustule, Rash, Skin exfoliation, Urticaria, |
||||
VEDOLIZUMAB, ADALIMUMAB, UPADACITINIB, USTEKINUMAB, |
||||
| 57 | 25127865 |
US |
64 | 2 |
Sensitive skin, Seasonal allergy, Dry skin, |
||||
RIPRETINIB, |
||||
| 58 | 25128061 |
US |
70 | 1 |
Product dose omission issue, Pruritus, Rash, Dry skin, |
||||
LENALIDOMIDE, |
||||
| 59 | 25128131 |
US |
1 | |
Dry skin, Oropharyngeal pain, Restless legs syndrome, Product use in unapproved indication, |
||||
TRAMETINIB, SIROLIMUS, |
||||
| 60 | 25128710 |
US |
1 | 1 |
Dry skin, Sleep disorder, Pruritus, Therapeutic response decreased, Dry eye, Eye irritation, Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 61 | 25128806 |
US |
78 | 1 |
Dry skin, Skin fissures, Sleep disorder due to a general medical condition, Pruritus, |
||||
DUPILUMAB, |
||||
| 62 | 25128810 |
US |
1 | |
Dry skin, Skin haemorrhage, |
||||
DUPILUMAB, LOSARTAN POTASSIUM, LOSARTAN, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, AMLODIPINE BESYLATE, MONTELUKAST SODIUM, MONTELUKAST, BUDESONIDE AND FORMOTEROL FUMARATE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 63 | 25128838 |
US |
2 | |
Dermatitis, Pruritus, Skin exfoliation, Dry skin, |
||||
DUPILUMAB, ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, BACLOFEN, ETANERCEPT, HYDROXYZINE, LINACLOTIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
| 64 | 25128852 |
US |
48 | 2 |
Dry skin, Pruritus, Dry eye, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 65 | 25128878 |
US |
54 | 2 |
Dry skin, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 66 | 25128887 |
US |
8 | 1 |
Dry skin, Skin fissures, Pruritus, |
||||
DUPILUMAB, |
||||
| 67 | 25128889 |
US |
5 | 1 |
Rash macular, Erythema, Sleep disorder due to a general medical condition, Pruritus, Ocular hyperaemia, Rash, Dry skin, Skin exfoliation, Eye irritation, Drug effect less than expected, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 68 | 25128917 |
US |
6 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 69 | 25128940 |
US |
6 | 2 |
Rebound eczema, Dry skin, Scab, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 70 | 25128954 |
US |
18 | 1 |
Abdominal pain upper, Dry skin, |
||||
DUPILUMAB, |
||||
| 71 | 25128983 |
US |
44 | 1 |
Dermatitis atopic, Pruritus, Dry skin, Skin exfoliation, Injection site pain, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 72 | 25129968 |
US |
7 | 2 |
Dry skin, Skin exfoliation, Pruritus, |
||||
DUPILUMAB, |
||||
| 73 | 25129973 |
US |
47 | 1 |
Eczema, Erythema, Dry skin, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 74 | 25130057 |
BR |
80 | 2 |
Fall, Femur fracture, Gait disturbance, Erysipelas, Hypersensitivity, Skin exfoliation, Dry skin, Erythema, Joint swelling, Memory impairment, |
||||
RIBOCICLIB, RIBOCICLIB, |
||||
| 75 | 25130591 |
US |
73 | |
Skin exfoliation, Dry skin, Hypertrichosis, Dry eye, Drug intolerance, |
||||
ISOTRETINOIN, |
||||
| 76 | 25130754 |
US |
80 | 2 |
Dry skin, Sneezing, Rhinorrhoea, Condition aggravated, Nasal congestion, Condition aggravated, Pruritus, Eye pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 77 | 25131846 |
US |
2 | |
Dry skin, Photosensitivity reaction, Skin hyperpigmentation, |
||||
PEMBROLIZUMAB, |
||||
| 78 | 25121197 |
US |
23 | 2 |
Eczema, Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 79 | 25121434 |
US |
23 | 1 |
Dry skin, Ocular hyperaemia, Dry eye, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 80 | 25121493 |
US |
4 | 2 |
Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 81 | 25121764 |
US |
39 | 1 |
Dermatitis atopic, Dry skin, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 82 | 25122020 |
US |
2 | |
Endometriosis, Seasonal allergy, Dermatitis, Type 2 diabetes mellitus, Dry skin, |
||||
RISANKIZUMAB-RZAA, |
||||
| 83 | 25122145 |
US |
67 | |
Diabetes mellitus, Decreased appetite, Fatigue, Dyspnoea, Insomnia, Night sweats, Injection site bruising, Wound, Epistaxis, Vision blurred, Constipation, Localised infection, Abdominal distension, Haemorrhagic diathesis, Dry skin, |
||||
ACALABRUTINIB, FOLIC ACID, INSULIN LISPRO, |
||||
| 84 | 25122255 |
US |
48 | 2 |
Acne, Pruritus, Dry skin, |
||||
TRALOKINUMAB-LDRM, |
||||
| 85 | 25123054 |
US |
||
Dry skin, Erythema, Off label use, |
||||
| 86 | 25123131 |
US |
2 | |
Adenovirus infection, Alopecia, Dry skin, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, EPINEPHRINE, ADRENALINUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ERGOCALCIFEROL, CICLOPIROX, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALPRAZOLAM, APIXABAN, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 87 | 25123301 |
US |
28 | 2 |
Eczema, Erythema, Periorbital swelling, Pruritus, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 88 | 25123427 |
RU |
8 | |
Eczema nummular, Dry skin, Eczema, Rash papular, Rash erythematous, |
||||
SELUMETINIB, |
||||
| 89 | 25123430 |
US |
1 | |
Cough, Dyspnoea exertional, Respiratory tract infection, Mobility decreased, Arthralgia, Muscular weakness, Dry skin, Acne, |
||||
CALCIUM CARBONATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 90 | 25123434 |
US |
2 | |
Pneumonia, Upper respiratory tract infection, Pruritus, Dry skin, Multiple allergies, |
||||
DUPILUMAB, TORSEMIDE, DICYCLOMINE HYDROCHLORIDE, BACLOFEN, SPIRONOLACTONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ERGOCALCIFEROL, MAGNESIUM, LISINOPRIL, NITROGLYCERIN, OXYGEN, 0XYGEN, EPINEPHRINE, ADRENALINUM, FAMOTIDINE, MELOXICAM, |
||||
| 91 | 25123726 |
PT |
76 | 1 |
Acute kidney injury, Atrial fibrillation, Cardiac failure, Respiratory failure, Haemorrhoidal haemorrhage, Hyperglycaemia, Rectal haemorrhage, Neuropathy peripheral, Neutropenia, Dry skin, Skin exfoliation, Erythema, Decreased appetite, Weight decreased, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, APIXABAN, BISOPROLOL FUMARATE, ROSUVASTATIN, |
||||
| 92 | 25124052 |
US |
17 | 2 |
Sleep disorder, Oligomenorrhoea, Dysmenorrhoea, Dry eye, Dermatitis atopic, Skin exfoliation, Skin fissures, Dry skin, Pruritus, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 93 | 25124088 |
US |
73 | 2 |
Dermatitis, Dry skin, Pruritus, Skin exfoliation, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 94 | 25124196 |
US |
39 | 1 |
Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Skin exfoliation, Pruritus, Erythema, Oral herpes, |
||||
DUPILUMAB, |
||||
| 95 | 25124472 |
FR |
40 | 2 |
Haematochezia, Flatulence, Fatigue, Rash maculo-papular, Dry skin, Vision blurred, Dry mouth, Peripheral sensory neuropathy, Abdominal pain, Constipation, Hot flush, Menstruation irregular, Amenorrhoea, Urinary incontinence, Cheilitis, Thirst, Lip dry, Insomnia, Cough, Tinnitus, Headache, Arthralgia, |
||||
LORLATINIB, |
||||
| 96 | 25125565 |
US |
1 | |
Dementia Alzheimer^s type, Dry skin, Asthma, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 97 | 25125929 |
US |
2 | |
Dry skin, Skin haemorrhage, |
||||
SIROLIMUS, ALPRAZOLAM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PAROXETINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 98 | 25126162 |
US |
||
Coeliac disease, Nausea, Dizziness, Dry skin, Headache, Inflammation, |
||||
PALIPERIDONE, |
||||
| 99 | 25115866 |
US |
20 | 2 |
Dry skin, Sleep disorder due to a general medical condition, Pruritus, |
||||
DUPILUMAB, |
||||
| 100 | 25116411 |
RU |
||
Dry skin, Hyperkeratosis, Paronychia, |
||||
SELUMETINIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28